Global Dialysis Machines and Consumables Market, By Type (Hemodialysis and Peritoneal), Product Type (Hemodialysis and Peritoneal Dialysis), Disease Type (Chronic and Acute), End Use (Hospitals, Dialysis Centers, Home Care Settings, and Others), Distribution Channel (Direct Tenders, Retail Sales, and Others) - Industry Trends and Forecast to 2031.
Dialysis Machines and Consumables Market Analysis and Insights
According to the World Health Organization (WHO), the global prevalence of Chronic Kidney Disease (CKD) is estimated to be around 13.4%, with higher rates in populations with diabetes, hypertension, and cardiovascular disease. According to the U.S. Renal Data System (USRDS), the incidence rate of End-Stage Renal Disease (ESRD) was approximately 357 cases per million population in 2018 in the U.S. Also, the American Cancer Society estimated that in 2022, there would be about 76,080 new cases of kidney cancer (46,240 in men and 29,840 in women).
Data Bridge Market Research analyzes that the global dialysis machines and consumables market is expected to reach USD 23.22 billion by 2031 from USD 16.41 billion in 2023, growing at a CAGR of 4.6% in the forecast period of 2024 to 2031.
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016–2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Pricing in USD
|
|
Segments Covered
|
Type (Hemodialysis and Peritoneal), Product Type (Hemodialysis and Peritoneal Dialysis), Disease Type (Chronic and Acute), End Use (Hospitals, Dialysis Centers, Home Care Settings, and Others), Distribution Channel (Direct Tenders, Retail Sales, and Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, U.K., Italy, France, Spain, Russia, Switzerland, Turkey, Belgium, Netherlands, Rest of Europe, Japan, China, South Korea, India, Singapore, Thailand, Indonesia, Malaysia, Philippines, Australia, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Egypt, Saudi Arabia, U.A.E., Israel, and Rest of Middle East and Africa
|
|
Market Players Covered
|
Fresenius SE & Co. KGaA, Baxter, NIPRO, Evoqua Water Technologies LLC, Medtronic, B. Braun SE, Nikkiso Co., Ltd., JMS Co. Ltd., Jafron Biomedical Co., Ltd., Asahi Kasei Medical Co., Ltd., Atlantic Biomedical, dialifegroup, and Advin Health Care, among others
|
Market Definition
Dialysis machines are medical devices used to filter and purify the blood of individuals with kidney failure. These machines mimic the functions of the kidneys by removing waste, salt, and excess water from the blood, and maintaining safe levels of certain chemicals in the body. They are typically used in hemodialysis, a process where blood is pumped out of the body, filtered through a dialyzer (artificial kidney), and then returned to the body.
Consumables for dialysis include items such as dialyzers, tubing sets, needles, bloodlines, dialysate solution, and various filters. These consumables are essential components of the dialysis process, enabling the machine to effectively filter the blood and remove waste products. Consumables are typically disposable and are used for a single treatment session before being discarded.
Global Dialysis Machines and Consumables Market Dynamics
This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- Increasing Prevalence of Kidney Diseases
With the global population aging and lifestyles becoming more sedentary, the incidence of kidney diseases is on the rise. CKD and ESRD require long-term management, often necessitating dialysis as a life-sustaining treatment. As a result, the demand for dialysis machines and consumables is expected to increase steadily. The increasing prevalence of kidney diseases, including CKD and ESRD, serves as a significant factor driving the market growth. Furthermore, the demand for dialysis machines and consumables is expected to escalate as the number of patients with kidney diseases continues to rise, particularly due to factors such as aging populations, lifestyle changes, and the increasing incidence of conditions such as diabetes and hypertension.
- Growing Demand for Home-based Dialysis Treatments
The growing demand for home dialysis trend is primarily driven by the increasing recognition of the benefits of home-based dialysis treatments, including greater convenience, flexibility, and cost-effectiveness compared to traditional in-center hemodialysis.
Home dialysis allows patients to undergo treatment in the comfort of their own homes, reducing the need for frequent visits to healthcare facilities and enabling them to maintain a more independent lifestyle.
Furthermore, advancements in technology have made home dialysis more accessible and user-friendly, leading to a greater acceptance of this treatment option among patients and healthcare providers. Home dialysis also allows for more frequent or longer dialysis sessions, which can lead to improved clinical outcomes and a better quality of life for patients with ESRD.
There is an increasing need for dialysis machines and consumables designed specifically for home use as the demand for home dialysis continues to grow. Manufacturers have an opportunity to develop innovative products that meet the unique requirements of home dialysis patients, such as smaller and more portable dialysis machines, easy-to-use consumables, and remote monitoring capabilities, which are propelling the market growth.
Restraint
- High Cost of Treatment in Developing Countries
The cost of dialysis treatment is a significant factor limiting the market growth, particularly for patients in developing countries or those without adequate insurance coverage. Dialysis treatment is a lifelong requirement for patients with ESRD, and the expenses can quickly accumulate, making it unaffordable for many individuals.
In addition, even in developed countries where healthcare systems are more robust, the cost of dialysis treatment can still be a significant financial burden for patients, especially those without adequate insurance coverage. This can result in delayed or suboptimal treatment, which can further impact patient outcomes and quality of life.
The high cost of dialysis treatment also affects healthcare providers and governments, as they are faced with the challenge of providing affordable and accessible dialysis services to a growing number of patients. This can strain healthcare budgets and resources, leading to gaps in care and disparities in access to treatment.
Opportunity
- Government Initiatives for Various Renal-Related Problems
Governments globally are realizing the significance of addressing the growing number of cases of ESRD and providing affected people with better access to dialysis treatments. They have laid in place many initiatives to improve patient access to treatment, develop dialysis infrastructure, and foster innovation in dialysis technology and care delivery models as part of larger efforts to transform the healthcare system.
Governments have the authority to provide funds for the opening of new dialysis facilities, the purchase of supplies and equipment for dialysis, and the education of medical staff in dialysis administration. They may also enact laws that enhance reimbursement rates, broaden insurance coverage for dialysis treatments, and lower patient out-of-pocket expenses to increase the affordability and accessibility of dialysis services. In addition, grants, tax breaks, and public-private partnerships can be used by governments to encourage R&D in the dialysis sector, resulting in innovative product design, manufacturing processes, and technological integration.
Challenge
- Shortage of Skilled Workforce For Conducting The Dialysis Procedure
The market is impacted by the lack of qualified healthcare workers in many ways, including nephrologists, dialysis nurses, technicians, and support staff. Lack of capacity of the staff may limit healthcare institutions' ability to fulfill the increasing demand for treatment, it limits the scalability of dialysis services. This restriction may result in lengthier dialysis appointment wait times, fewer options for patients to receive treatment and greater demands for medical professionals.
Moreover, an inadequate number of labor complicates problems with the quality of care since overworked medical staff may become burned out, become exhausted, and find it difficult to give dialysis patients prompt, thorough care. As a result, there may be less patient satisfaction, worse treatment outcomes, and a higher chance of problems. Furthermore, healthcare institutions lack the knowledge and resources to support and implement new practices, and a lack of experienced workers may impede the adoption of modern technologies or treatment modalities.
Dialysis service scalability is hampered by the shortage, which results in lengthier treatment longer delay times, and fewer options for patients. Overworked staff members may provide inadequate assistance, increasing patient risks and treatment outcomes that fall short of ideal. Furthermore, by impeding the uptake of novel techniques and technologies, the scarcity restricts the expansion and advancement of the market. Thus, the shortage of workforce for the treatment of dialysis or related issues is expected to act as a challenge to market growth.
Recent Developments
- In August 2023, Fresenius SE & Co. KGaA announced the FDA's 510(k) clearance for Versi HD with GuideMe Software, a fully redesigned self-guided interface for the company's VersiHD chronic Home Hemodialysis (HHD) equipment. The goal of VersiHD with GuideMe Software is to change how nurses and patients see HHD. This helped the company to expand its product line with availability in the market
- In April 2023, Medtronic and DaVita Inc. jointly launched Mozarc Medical, an independent company dedicated to transforming kidney health and advancing patient-centered technology solutions
- In January 2022, Evoqua Water Technologies LLC finalized the acquisition of the renal business formerly operated by Mar Cor Purification, a subsidiary of STERIS Plc. This acquisition will broaden Evoqua's service presence in North America, strengthening its position in the healthcare sector
- In December 2021, ExThera Medical and Asahi Kasei Medical Co., Ltd., a core operating company of the Asahi Kasei Group, signed an exclusive distribution agreement in Japan for ExThera's Seraph 100 Microbind Affinity Blood Filter (Seraph 100). Under the agreement, ExThera Medical and Asahi Kasei Medical Co., Ltd. collaborated to secure regulatory approval of Seraph 100 for commercialization in Japan. This agreement, as a significant step, helped the company in the expansion of the intensive care business field
Global Dialysis Machines and Consumables Market Scope
The global dialysis machines and consumables market is segmented into five notable segments based on type, product type, disease type, end use, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the differences in your target markets.
Type
- Hemodialysis
- Peritoneal
On the basis of mode of type, the market is segmented into hemodialysis and peritoneal.
Product Type
- Hemodialysis
- Peritoneal Dialysis
On the basis of product type, the market is segmented into hemodialysis and peritoneal dialysis.
Disease Type
- Chronic
- Acute
On the basis of disease type, the market is segmented into chronic and acute.
End Use
- Hospitals
- Dialysis Centers
- Home Care Settings
- Others
On the basis of end use, the market is segmented into hospitals, dialysis centers, home care settings, and others.
Distribution Channel
- Direct Tenders
- Retail Sales
- Others
On the basis of distribution channel, the market is segmented into direct tenders, retail sales, and others.
Global Dialysis Machines and Consumables Market Regional Analysis/Insights
The global dialysis machines and consumables market is segmented into five notable segments based on type, product type, disease type, end use, and distribution channel.
The countries covered in this market report are U.S., Canada, Mexico, Germany, U.K., Italy, France, Spain, Russia, Switzerland, Turkey, Belgium, Netherlands, rest of Europe, Japan, China, South Korea, India, Singapore, Thailand, Indonesia, Malaysia, Philippines, Australia, rest of Asia-Pacific, Brazil, Argentina, rest of South America, South Africa, Egypt, Saudi Arabia, U.A.E., Israel, and rest of Middle East and Africa.
North America is expected to dominate the market with favorable reimbursement policies for dialysis treatment. The U.S. is expected to dominate in the North America region due to the presence of market players and improving R&D in the healthcare sector. The region's early tech adoption and mature market contribute to a strong demand for advanced solutions. Japan is expected to dominate in the Asia-Pacific region due to its vast landmass, large pool of geriatric patients, and increasing prevalence of kidney diseases. Germany is expected to dominate in the Europe region due to its advanced technology adoption, robust healthcare infrastructure, and mature market.
The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands and the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Dialysis Machines and Consumables Market Share Analysis
The global dialysis machines and consumables market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product approvals, product width and breadth, application dominance, and product type lifeline curve. The above data points provided are only related to the company’s focus on the market.
Some of the major market players operating in the market are Fresenius SE & Co. KGaA, Baxter, NIPRO, Evoqua Water Technologies LLC, Medtronic, B. Braun SE, Nikkiso Co., Ltd., JMS Co. Ltd., Jafron Biomedical Co., Ltd., Asahi Kasei Medical Co., Ltd., Atlantic Biomedical, dialifegroup, and Advin Health Care, among others.
SKU-